- Series: Decoding Cancer-Associated Cachexia — From Basics to Breakthroughs | Part 5
What Works Today — Nutrition, Exercise, Anti-inflammation, and Current Drugs Part 5 is a how-to guide. We alig […]
- Series: Decoding Cancer-Associated Cachexia — From Basics to Breakthroughs | Part 4
What Breaks in CAC? — Human Evidence on Appetite, Metabolism, Fat & Muscle In Part 4 we look behind the sc […]
- Series: Decoding Cancer-Associated Cachexia — From Basics to Breakthroughs | Part 3
Making CAC Visible — Phenotyping with CT, Function, and PROs Part 3 is a practical guide to phenotyping in cli […]
- Series: Decoding Cancer-Associated Cachexia — From Basics to Breakthroughs | Part 2
Don’t Miss It — Home & Clinic Checklists + FAQs Part 2 is a hands-on template pack. Use these copy-and-pas […]
- Series: Decoding Cancer-Associated Cachexia — From Basics to Breakthroughs | Part 1
What Is CAC? — The Disease You Can’t See by Weight Alone This is a “super-basic” primer for patients, families […]
- New Horizons in Biliary Tract Cancer: Insights from Cancer Discovery on Molecular Subtypes and Therapeutic Targets
Biliary tract cancer (BTC), encompassing intrahepatic and extrahepatic cholangiocarcinoma as well as gallbladd […]
- Glioblastoma Series | Part 9 (Finale): Fewer Moves, Deeper Reach — Answering Plasticity, Diversity, and State Shifts
Fewer Moves, Deeper Reach — Answering Plasticity, Diversity, and State Shifts This closing chapter weaves the […]
- Glioblastoma Series | Part 8: Who Excels Where? — Country Strengths, Access Gaps, and Implementation Paths
Who Excels Where? — Country Strengths, Access Gaps, and Implementation Paths The same plan can reach very diff […]
- Glioblastoma Series | Part 7: Global Landscape — A Modality-by-Modality Development Map
Global Landscape — A Modality-by-Modality Development Map Building on seed (pre-CC), niche (microenvironment), […]
- Glioblastoma Series | Part 6: Seeing What Matters — Composite Diagnostics (Imaging × Transcriptome × CNV)
Seeing What Matters — Composite Diagnostics (Imaging × Transcriptome × CNV) Therapy moves only when we can ans […]